Sentences with phrase «month average survival time»

Not exact matches

Glioblastoma is the most aggressive type of tumor that originates in the brain and with no curative treatments currently available, the average survival time for patients ranges from 15 to 18 months.

Usually, treatment would require whole - brain radiation which is extremely toxic and the average survival time is just 3 - 6 months from diagnosis, with fewer than 20 per cent of patients surviving more than one year.

These same patients also had significantly longer average survival times (36 months) compared to patients with high ERCC1 levels (10 months).

Similarly, 29 patients had low TS levels and significantly longer average survival times (36 months) than patients with high TS levels (15 months).

Among patients with metastatic melanomas with the worst prognosis (stage M1c), the average progression - free survival times were 8.5 months for the combination treatment, 5.4 months for nivolumab alone and 2.8 months for ipilimumab alone.

Patients younger than 65 years, had average progression - free survival times of 11.7 months (combination), 5.5 months (nivolumab) and 2.8 months (ipilimumab), while the 262 patients aged between 65 and 75 had average progression - free survival times of 11.1 months, 12.7 months and 2.9 months respectively.

For those aged 75 and over (118 patients), the average progression - free survival time for those on the combination treatment could not be calculated as the patients» disease had not progressed yet; it was 5.3 months for those on nivolumab alone and four months for those on ipilimumab alone.

When the researchers looked at progression - free survival times among patients with and without the V600 type of mutation of the BRAF gene, the average for patients taking both drugs without the mutation was 11.2 months, and it was 11.7 months for those with the mutation.

The average progression - free survival — the time from randomization to the first evidence of metastasis — was 40.5 months for participants receiving apalutamide, compared with 16.2 months for those taking a placebo.

The most common form of lymphoma seen in dogs progresses rapidly and if untreated, the average survival time is about two months.

These cats show an average survival time of 9 - 12 months, with the initial response to treatment often giving an indication of survival time.

Mediastinal lymphoma in cats with feline leukemia carries a poor prognosis, with an average survival time of 3 months.

One study shows the average survival time of dogs with enlarged heart is anywhere from 6 months to 12 months, with very few cases where a dog survives 1.5 years (source).

For those dogs that have the most common type (external lymph nodes enlargement), the average remission time is usually around 8 - 10 months with an overall survival time of about 1 year.

Only a few studies have evaluated treatment of this disease, and the most successful treatment (to date) that we know of involves a relatively invasive surgery to remove the sac around the heart followed by a course of chemotherapy, leading to survival times averaging about 6 months.

After removal of the spleen, the average survival time is about three months.

The average survival time with chemotherapy is 3.5 months for virus positive cats and 5 months for non-viral infected cats.

In one study of dogs that had anamputation for a histiocytic sarcoma affecting a joint, the average survival time was six months.

If a dog has a single colrectal carcinoma the average survival time is 32 months.

Those who were tracked that had the surgery between 2005 and 2013 had an average survival time of 35 months.